Future studies will focus on investigating the ability of B cells from individuals with type 1 diabetes to migrate in response to physiological levels of CXCL10 and CXCL11, in the presence and absence of BAFF. The gene discussed is CXCL11; the disease is type 1 diabetes mellitus.